cas 1411774-27-0|| where to buy (3R)-3-Fluoropyrrolidine-1-sulfonylchloride

Nom du produit:(3R)-3-Fluoropyrrolidine-1-sulfonylchloride

IUPAC Name:(3R)-3-fluoropyrrolidine-1-sulfonyl chloride

: CAS：1411774-27-0; Formule moléculaire：C4H7ClFNO2S; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)
CM419801-100mg	in stock	ȷƻ
CM419801-250mg	in stock	ſȷ
CM419801-1g	in stock	ƻƋȷ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1411774-27-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1411774-27-0; Formule moléculaire:C4H7ClFNO2S; Point de fusion:-; Code SMILES:F[C@@H]1CCN(C1)S(Cl)(=O)=O; Densité:

: Numéro de catalogue:CM419801; Poids moléculaire:187.61; Point d'ébullition:; N° Mdl:; Stockage:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Plixorafenib; FORE Biotherapeutics’s Plixorafenib (PLX-8394) is a next-generation, orally selective inhibitor and specific dimer breaker of BRAF protein under clinical development. Its favorable efficacy and tolerability are updated in the recently presented phase 1/2a results in BRAF V600 advanced solid tumors. Plixorafenib was designed to target a wide range of BRAF mutations while sparing wild type forms of RAF. It has been granted Fast Track Designation and Orphan Drug Designation from the U.S. FDA.